Irina Shevchenko

Dr. Irina Shevchenko


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2024 in Medicina
Verified
Journal Article
Open access
PDF file
ISIrina Shevchenko
Irina Shevchenko
CGCatalin Cicerone Grigorescu
Catalin Cicerone Grigorescu
Dragos SerbanDragos Serban
Dragos Serban
BCBogdan Mihai Cristea
Bogdan Mihai Cristea
Laurentiu SimionLaurentiu Simion
Laurentiu Simion
ADAna Dascalu
Ana Dascalu
Background and Objectives: Systemic inflammatory indices have been largely investigated for their potential predictive value in multiple inflammatory, infectious, and oncological diseases; however, their value in colorectal cancer is still a subject of research. This study investigates the dynamics of pre- and postoperative values of NLR, PLR, SII, and MLR in patients with colorectal cancer and their predictive value for early postoperative outcomes. Materials and Methods: A 2-year retrospective cohort study was performed on 200 patients operated for colorectal adenocarcinoma. Systemic inflammatory indices were calculated based on complete blood count preoperatively and on the first and sixth postoperative days. The patients were divided into two groups based on their emergency or elective presentation. The pre- and postoperative values of serum inflammatory biomarkers and their correlations with postoperative outcomes were separately analyzed for the two study subgroups. Results: There were no significant differences in sex distribution, addressability, associated comorbidities, or types of surgery between the two groups. Patients in the emergency group presented higher preoperative and postoperative values of WBC, neutrophils, NLR, and SII compared to elective patients. The postsurgery hospital stays correlated well with pre- and postoperative day one and day six values of NLR (p = 0.001; 0.02; and <0.001), PLR (p < 0.001), SII (p = 0.037; <0.001; <0.001), and MLR (p = 0.002; p = 0.002; <0.001). In a multivariate analysis, reintervention risk was higher for emergency presentation and anemia, and lower in right colon cancer. In the emergency group, a multivariate model including age, MLR PO1, and pTNM stage was predictive for severe postoperative complications (AUC ROC 0.818). First-day postoperative inflammatory indices correlated well with sepsis, with the best predictive value being observed for the first postoperative day NLR (AUC 0.836; sensibility 88.8%; specificity 66.7%) and SII (AUC 0.796; sensitivity 66.6%; specificity 90%). For elective patients, the first postoperative day PLR and anemia were included in a multivariate model to predict Clavien–Dindo complications graded 3 or more (AUC ROC 0.818) and reintervention (AUC ROC 0.796). Conclusions: Easy-to-calculate and inexpensive systemic inflammatory biomarkers could be useful in predicting early postoperative outcomes in colorectal cancer for both elective and emergency surgery.

Verified
Journal Article
Open access
PDF file
ISIrina Shevchenko
Irina Shevchenko
Dragos SerbanDragos Serban
Dragos Serban
Laurentiu SimionLaurentiu Simion
Laurentiu Simion
IMIon G. Motofei
Ion G. Motofei
BCBogdan Mihai Cristea
Bogdan Mihai Cristea
DCDaniel Ovidiu Costea
Daniel Ovidiu Costea
Background/Objectives: Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide. Despite advancements in surgical techniques and oncological treatments, postoperative complications remain a significant challenge, affecting both immediate recovery and long-term survival. Systemic inflammation has been identified as a critical factor influencing cancer progression and postoperative outcomes. This systematic review evaluates the clinical significance of blood cell-derived inflammatory markers in predicting early and late postoperative complications in CRC patients. Methods: We included studies involving adult patients (≥18 years) with histologically confirmed colorectal cancer, for whom elective radical surgery was performed, as well as at least one of the considered blood-based inflammatory biomarkers (NLR, PLR, SII, or LMR) documented in relation to outcomes. Results: After removing duplicates, 19 studies published between 2016 and 2025 were included in the qualitative analysis. A total of 7023 patients who underwent elective curative surgery for colorectal cancer were analyzed, with mean age varying widely between 47.3 and 74.6 years. Preoperative NLR values were significantly correlated with severe complications, IAI, AL, and overall complications in 13 out of 19 studies (68.4%), with a cutoff value between 2.21 and 4, while early postoperative NLR values were predictive for AL. Late postoperative complications, such as recurrence and overall survival, were also associated with elevated preoperative NLR and PLR values. However, variability in study designs, patient populations, and cutoff values for these indices contributed to inconsistent findings. Conclusions: Blood cell-derived inflammatory markers offer a valuable, non-invasive tool for assessing postoperative risks in patients with CRC. New design nomograms or risk scores that include, beside blood cell-derived inflammation markers, other relevant data, could ensure an optimal predictive value that could be easily used in clinical practice for personalized risk management in patients with colorectal cancer.

29 October 2026 in Medicina
Verified
Journal Article
Open access
PDF file
CACatalin Alius
Catalin Alius
Dragos SerbanDragos Serban
Dragos Serban
VGVlad Alexandru Gâta
Vlad Alexandru Gâta
RIRadu Alexandru Ilies
Radu Alexandru Ilies
GFGerald Filip
Gerald Filip
TBTudor Mihai Badescu
Tudor Mihai Badescu
Background and Objectives: In difficult clinical settings, laparoscopic cholecystectomy remains linked to higher conversion rates, prolonged operative time and an increased risk of bile duct injury. Near-infrared fluorescence cholangiography using indocyanine green (ICG) was developed as a real-time intraoperative imaging technique aimed at improving biliary anatomy visualization, reducing the need for cystic duct cannulation or use of ionizing radiation. We hypothesize that the variable performance of ICG fluorescence cholangiography might not be an intrinsic property of the technique, depending instead on the administration protocol, the specifications of the NIR devices and technical factors, patient characteristics, and the severity of the disease. The aim of the present narrative review with systematic search is to critically evaluate the available primary clinical evidence on the role of ICG fluorescence cholangiography as a tool in general and in difficult laparoscopic cholecystectomy, with special focus on biliary anatomy visualization, protocol heterogeneity, operative outcomes and evidence limitations. Materials and Methods: We conducted a systematic literature search in PubMed, Cochrane Library, and Web of Science to identify original studies published between 2015–2026 that evaluated ICG fluorescence during laparoscopic cholecystectomy. Afterwards, findings were synthesized narratively based on clinically relevant themes. Results: A total of 24 studies were included in the analysis. Several studies reported improved visualization of biliary anatomy using ICG fluorescence compared to conventional white-light imaging. Visualization improved with progression of dissection in Calot’s triangle. Potential clinical benefits suggested for technically difficult procedures (acute cholecystitis, severe inflammation, presence of adhesions, obese patients or distorted anatomy) remain uncertain, as these conditions also reduce fluorescence visibility. Some studies reported shorter times to biliary structure identification and achievement of the critical view of safety. Considerable heterogeneity persists regarding several variables: ICG dose and timing, the route of administration, and patient selection. Conclusions: Globally, the main benefits of ICG fluorescence cholangiography are the enhancement of biliary anatomy identification and the improvement of operative efficiency. Future randomized trials using standardized fluorescence protocols are needed to determine the optimal administration routes and doses of ICG and identify whether improved visualization translates into meaningful surgical and clinical improvements.